Learn More
Cayman Chemical Cisplatin, 15663-27-1, 250 mg

Supplier: Cayman Chemical 13119250
A DNA-crosslinking agent; halts the cell cycle at the G2/M phase in vitro; active against murine tumors transplanted into mice and in mouse xenograft models; reduces tumor growth in a squamous cell carcinoma mouse xenograft model at doses of 7.5-12.5 mg/kg; inhibits RecA recombinase of M. tuberculosis (IC50 = 2 µM)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.